Redhill Biopharma Ltd (RDHL) ADR Each Representing 1000 Ord Shares SPON

Sell:$1.01Buy:$1.06Price increased$0.01 (0.97%)

Prices delayed by at least 15 minutes
Sell:$1.01
Buy:$1.06
Change:Price increased$0.01 (0.97%)
Prices delayed by at least 15 minutes
Sell:$1.01
Buy:$1.06
Change:Price increased$0.01 (0.97%)
Prices delayed by at least 15 minutes

Key metrics

Open$1.03
Previous close$1.03
Market cap$5.27m
P/E ratio-
Volume74,317
Dividend yield0.00%
EMS-

RedHill Biopharma Ltd is an Israel-based specialty biopharmaceutical company primarily focused on gastrointestinal and infectious diseases. RedHill promotes the gastrointestinal drugs such as, Talicia for the treatment ...

  • LocationIsrael
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyUSD
  • Shares in issue33.30bn

Take a closer look at this company’s financial statements and dividend information.

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.